Redsense’s operations continue unabatedly; no immediate operational risks from COVID-19
Further to recent developments of the ongoing COVID-19 outbreak on Redsense Medical AB’s markets, the Company announces the following statement regarding the Company’s current operations. Thanks to a well established domestic organization in the US, the Company is not expecting any supply disruptions from the US travel ban, and the COVID-19 outbreak is not expected to impact Redsense’s operations directly.The US administration has on 12 March decided to impose a 30-day travel ban, suspending travel from Europe except the UK to the US, in an effort to contain the Coronavirus from spreading.